Respuestas clínicas Cochrane
Las Respuestas Clínicas de la Cochrane (CCA) proporcionan un punto de entrada legible, sencillo y con enfoque clínico a la investigación rigurosa de las revisiones sistemáticas de la Cochrane. Están diseñadas para ser procesables e informar sobre la toma de decisiones en el punto de atención médica y se han añadido a las secciones pertinentes del texto principal de las Best Practice.
- How does tofacitinib compare with placebo for maintaining remission in people with ulcerative colitis?
- Is there randomized controlled trial evidence to support the use of etrolizumab for induction of remission in people with ulcerative colitis?
- What are the effects of antibiotics for the induction and maintenance of remission in people with ulcerative colitis?
- For maintenance of remission in people with ulcerative colitis, how do probiotics compare with mesalazine (5‐ASA)?
- Can adding probiotics to standard concomitant drug treatment improve outcomes over standard treatment alone in adults and children with ulcerative colitis?
- What are the effects of fecal microbiota transplantation (FMT) for people with ulcerative colitis?
- How does surveillance compare with no surveillance for detecting colon cancer in people with ulcerative colitis or inflammatory bowel disease?
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad